Sientra (NASDAQ:SIEN) Now Covered by StockNews.com

Research analysts at StockNews.com assumed coverage on shares of Sientra (NASDAQ:SIEN) in a research note issued to investors on Thursday. The brokerage set a “hold” rating on the medical instruments supplier’s stock.

Sientra Stock Performance

Sientra has a 52 week low of $0.16 and a 52 week high of $4.94. The business’s 50 day moving average is $0.46 and its two-hundred day moving average is $1.18. The firm has a market capitalization of $2.08 million, a PE ratio of -0.03 and a beta of 2.04.

Institutional Investors Weigh In On Sientra

Institutional investors have recently made changes to their positions in the stock. LPL Financial LLC acquired a new stake in shares of Sientra during the second quarter worth $31,000. Wolverine Trading LLC acquired a new position in Sientra in the second quarter valued at about $32,000. Tower Research Capital LLC TRC acquired a new position in Sientra in the second quarter valued at about $33,000. Mirabella Financial Services LLP acquired a new position in Sientra in the first quarter valued at about $26,000. Finally, Advisor Group Holdings Inc. grew its stake in Sientra by 230.9% in the first quarter. Advisor Group Holdings Inc. now owns 11,930 shares of the medical instruments supplier’s stock valued at $26,000 after acquiring an additional 8,325 shares during the period. 15.38% of the stock is owned by institutional investors and hedge funds.

Sientra Company Profile

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.